Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial

• Main Authors: Julia Karady (Author), Robert W McGarrah (Author), Maggie Nguyen (Author), Stephanie N Giamberardino (Author), Nandini Meyersohn (Author), Michael T Lu (Author), Pedro V Staziaki (Author), Stefan B Puchner (Author), Daniel O Bittner (Author), Borek Foldyna (Author), Thomas Mayrhofer (Author), Margery A Connelly (Author), Andre Tchernof (Author), Phillip J White (Author), Khurram Nasir (Author), Kathleen Corey (Author), Deepak Voora (Author), Neha Pagidipati (Author), Geoffrey S Ginsburg (Author), William E Kraus (Author), Udo Hoffmann (Author), Pamela S Douglas (Author), Svati H Shah (Author), Maros Ferencik (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: To determine the relationship between lipoprotein particle size/number with hepatic steatosis (HS), given its association with traditional lipoproteins and coronary atherosclerosis. Methods: Individuals with available CT data and blood samples enrolled in the PROMISE trial were studied....